Laboratory Values Indicating Need for Intravenous Iron Therapy
Intravenous iron is indicated when serum ferritin is <100 μg/L and/or transferrin saturation is <20%, with specific thresholds varying by clinical condition. 1
General Diagnostic Thresholds
The most recent guidelines establish clear laboratory cutoffs for iron deficiency requiring treatment:
- Serum ferritin <100 μg/L is the primary diagnostic threshold across most conditions 1, 2
- Transferrin saturation <20% serves as an alternative or complementary marker 1, 2
These values should guide your decision-making, though specific clinical contexts modify these thresholds significantly.
Condition-Specific Laboratory Criteria
Chronic Kidney Disease (CKD)
The thresholds differ substantially in renal patients:
- Predialysis and peritoneal dialysis patients: Ferritin ≤100 μg/L with transferrin saturation ≤20% 1
- Hemodialysis patients: Ferritin ≤200 μg/L with transferrin saturation ≤20% 1
Critical caveat: In CKD, ferritin interpretation is complicated by inflammation. You must measure both ferritin and transferrin saturation together, as ferritin alone can be falsely elevated 1, 3.
Chronic Heart Failure (CHF)
Heart failure patients require IV iron with more liberal criteria:
- Ferritin <100 μg/L (absolute iron deficiency) 1
- OR transferrin saturation <20% (functional iron deficiency) 1
Importantly, both absolute and functional iron deficiency warrant IV iron in CHF, as this has demonstrated prognostic benefit for mortality and quality of life. Oral iron should be avoided in CHF due to poor absorption from gut edema 1.
Inflammatory Bowel Disease (IBD)
In the presence of inflammation:
- Ferritin up to 100 μg/L may still reflect iron deficiency due to ferritin's role as an acute phase reactant 1
- Transferrin saturation becomes more reliable in this context 1
- IV iron is indicated when hemoglobin <100 g/L with documented iron deficiency, or when oral iron is not tolerated 1
When to Choose IV Over Oral Iron
Beyond the laboratory values, IV iron is specifically indicated when 4:
- Hemoglobin fails to increase by 1 g/dL within 2 weeks of oral supplementation
- Ferritin fails to increase within 1 month despite adherent oral therapy
- Malabsorption conditions exist: post-bariatric surgery, active IBD, celiac disease
- Iron loss exceeds oral absorption capacity: ongoing bleeding, hemodialysis
- Oral iron intolerance: occurs in 12% (constipation), 8% (diarrhea), 11% (nausea) 4
Treatment Targets
Once you initiate IV iron, monitor for these laboratory endpoints:
- Hemoglobin target: 10-12 g/dL or normalization 2
- Ferritin target: >100 μg/L in most conditions 2
- In CKD: 200 μg/L, but do not exceed 500-800 μg/L to avoid iron overload 2
- Transferrin saturation target: 20-50% (when used as a monitoring parameter) 2
Critical Pitfalls to Avoid
Do not rely on ferritin alone in inflammatory states. Chronic inflammation, infection, malignancy, and liver disease all elevate ferritin independent of iron stores. In these patients, transferrin saturation <20% is more reliable for diagnosing functional iron deficiency 1.
Do not delay IV iron waiting for oral iron trials in patients with severe anemia (Hb <100 g/L), malabsorption, or ongoing losses. The 2-4 week trial period for oral iron is only appropriate in stable patients with mild-moderate anemia 4, 1.
Hypochromic red cells >10% (normal <2.5%) directly reflect iron-deficient erythropoiesis when flow cytometry is available, though this test is not universally accessible 3.